RxDoctor Payments Data

Sean Rogers, DO

Family Medicine · Springfield, PANPI 1396321774

Payments from drug & device makers

$1,237in general payments, 2019–2025

Across 11 payments — averaging $112.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Phathom Pharmaceuticals, Inc.$246
  • Pfizer$242
  • Heartflow, Inc.$127
  • AstraZeneca$126
  • AbbVie$125
  • Otsuka America Pharmaceutical, Inc.$122
  • plus $249 from 3 others

What the payments were for

  • Food & beverage$1,237100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,237 in reported general payments places this provider in the 70th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$25,794
Medicare patients
169
Services billed
261

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban14$25,706
OzempicSemaglutide20$23,067
Rosuvastatin Calcium46$851
Valsartan11$621
Ipratropium Bromide35$611
Atorvastatin Calcium47$511
Pantoprazole Sodium20$402
Levothyroxine Sodium30$392
Losartan Potassium28$370
Albuterol Sulfate HfaAlbuterol Sulfate11$344
Gabapentin23$339
Lisinopril24$220
Azelastine Hcl11$217
Metoprolol Succinate16$214
Fluticasone Propionate33$213

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$242$25,70614 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Springfield

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →